0001659819-15-000001.txt : 20151201 0001659819-15-000001.hdr.sgml : 20151201 20151201171505 ACCESSION NUMBER: 0001659819-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151201 DATE AS OF CHANGE: 20151201 EFFECTIVENESS DATE: 20151201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Velicept Therapeutics, Inc. CENTRAL INDEX KEY: 0001659819 IRS NUMBER: 473400632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-252193 FILM NUMBER: 151263025 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DRIVE STREET 2: SUITE 400 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-318-2988 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DRIVE STREET 2: SUITE 400 CITY: MALVERN STATE: PA ZIP: 19355 D 1 primary_doc.xml X0707 D LIVE 0001659819 Velicept Therapeutics, Inc. 101 LINDENWOOD DRIVE SUITE 400 MALVERN PA PENNSYLVANIA 19355 484-318-2988 DELAWARE None None Corporation true 2015 James Walker 101 Lindenwood Drive Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Douglas Gessl 101 Lindenwood Drive Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Stephen Tullman 101 Lindenwood Drive Suite 400 Malvern PA PENNSYLVANIA 19355 Director Scott Morenstein 500 Park Avenue New York NY NEW YORK 10022 Director David Hirsch One Fawcett Place Greenwich CT CONNECTICUT 06830 Director James Bennethum 860 Porcupine Path Gaylord MI MICHIGAN 49735 Director Pharmaceuticals Decline to Disclose 06b false 2015-11-23 true true false 4485 MTS Securities, LLC 104059 None None 623 Fifth Avenue 14th Floor New York NY NEW YORK 10022 All States false William Blair & Company 1252 None None 125 High Street Oliver Tower, Suite 1901 Boston MA MASSACHUSETTS 02110 All States false 21050003 12028576 9021427 true 2 24 1251429 true 0 $571,429 is currently due to MTS; estimated payments of $430,000 to MTS and $250,000 to William Blair will be due upon the sale of the remaining $9,021,427 of securities in the Offering. 700000 true false Velicept Therapeutics, Inc. James Walker James Walker President and CEO 2015-12-01